<SEC-DOCUMENT>0001569706-18-000002-index.html : 20181106
<SEC-HEADER>0001569706-18-000002.hdr.sgml : 20181106
<ACCEPTANCE-DATETIME>20181106172640
ACCESSION NUMBER:		0001569706-18-000002
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20181029
FILED AS OF DATE:		20181106
DATE AS OF CHANGE:		20181106

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Averback Paul
		CENTRAL INDEX KEY:			0001569706

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12033
		FILM NUMBER:		181164026

	MAIL ADDRESS:	
		STREET 1:		C/O NYMOX PHARMACEUTICAL CORPORATION
		STREET 2:		9900 CAVENDISH BLVD., SUITE 306
		CITY:			ST. LAURENT
		STATE:			A8
		ZIP:			H4M 2V2

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NYMOX PHARMACEUTICAL CORP
		CENTRAL INDEX KEY:			0001018735
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		9900 CAVENDISH BLVD., SUITE 306
		STREET 2:		ST. LAURENT
		CITY:			QUEBEC CANADA
		STATE:			A8
		ZIP:			H4M 2V2
		BUSINESS PHONE:		1-800-936-9669

	MAIL ADDRESS:	
		STREET 1:		9900 CAVENDISH BLVD., SUITE 306
		STREET 2:		ST. LAURENT
		CITY:			QUEBEC CANADA
		STATE:			A8
		ZIP:			H4M 2V2
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>